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Most	Common• High	fever	(usually	above	100.4˚F)• Chills• Night	sweats• Headaches• Shortness	of	breath• Cough• Cardiac	murmmurs• Fatigue• Muscle	and	joint	pain
Other	Symptoms
Host-Pathogen	Interaction:	Pathogens	adhere	to	the	exposed	extracellular	matrix	proteins,	referred	to	as	Microbial	Surface	Component	Reacting	with	Adhesive	Matric	Molecules,	released	by	the	non-bacteral	thrombotic	vegetation.	After	the	pathogen	adheres	to	the	vegetation,	colonization	and	invasion	of	the	myocardium	occurs	and	maintains	the	inflammatory	and	coagulation	processes.	The	vegetation	will	continue	to	grow	(neoangiogenesis)	and	distroy	the	valve	tissue.	(Thuny,	2016.	p.	1-2)
Signs	&	Symptoms
Significance	of	Pathophysiology
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•Intravenous	drug	use	(IVDU)	poses	many	risks	to	those	who	use	them.	One	of	the	risks	being	infective	endocarditis.	•“Infective	endocarditis	(IE)	is	an	infectious	microbial	disease	of	the	heart	valvular	endothelium.• The	characteristic	lesion	consists	of	the	presence	of	vegetations	that	can	settle	in	the	valvular	veils,	tendon	cords	or	mural	endocardium”	(Molinos,	2018,	p.	1).	•Complications	of	IE	include:	congestive	heart	failure,	embolization	of	septic	emboli	to	other	organs,	periannular	extension	of	infection,	metastatic	foci	of	infection,	mycotic	aneurysms,	and	anticoagulation	issues	(Baddour,	et.	al.,	2015,	pp.	32-37).	• Contemporary	multicentre	assessments	of	outcomes	in	IE	have	estimated	inpatient	mortality	between	14%	and	18%	(Tung	et.	al,	2015,	p.412).
Underlying	Lesion: Degenerative	processes	such	as	fibrosis,	calcification,	congenital	heart	diseases,	mechanical	lesions	secondary	to	material	implantation,	and	turbulent	blood	flows	(IVDU)	causes	endocardial	damage.	This	then	exposes	the	extracellular	matrix	and	results	in	apoptosis	of	endocardial	cells	which	then	produces	tissue	factor	and	a	non-bacterial	thrombus	formation.	This	thrombotic	formation	is	known	as	a	“vegetation.”	(Thuny,	2016,	p.1)
• In	the	instance	of	IVDU,	the	pathogen	is	introduced	into	the	host	via	bacteria	located	on	the	skin,	the	needle,	or	the	substance	being	injected.	The	key	factor	required	for	IVDU	to	cause	IE	is	myocardial	tissue	damage	that	has	produced	a	vegetation.	Research	shows	that	chronic	IVDU	can	cause	non-bacterial	vegetations	on	heart	valves	due	to	the	repetitive	damage	from	injected	particular	matter	(UpToDate,	2018)• According	to	Lapkus	and	Prahlow	(2015),	“the	risk	of	IE	in	IVDU	is	estimated	at	2%-5%	per	year	(p.	610)• “Staphylococcus	aureus	accounts	for	more	than	one-half	of	cases	of	IE	among	IVDUs.	Streptococci	and	enterococci	are	the	next	most	common	pathogens.	Less	commonly,	fungi	and	gram-negative	bacilli	can	also	cause	IE	in	IDUs”	(UpToDate,	2018).
Implications	for	Nursing	Care
• Assess	patients	for	signs	and	symptoms	of	IE	and	report	findings	timely	to	the	physician.	•Obtain	a	thorough	health	history,	specifically	regarding	cardiac	and	IVDU	history.• If	a	patient	has	a	confirmed	IE	(especially	left	sided),	monitor	the	patient	for	complications	such	as	emobolization of	the	vegetation	to	other	organs	(decreased	urine	output,	confusion,	abdominal/back	pain,	shortness	of	breath,	increasing	chest	pain).•Nurses	must	also	know	the	correct	procedure	for	drawing	blood	cultures	in	order	to	avoid	contamination	of	the	specimen.	• The	nurse	must	also	be	able	to	properly	educate	the	patient	on	IVDU	cessation	and	the	instance	of	reoccurrence	of	IE	in	IVDU.	
IE	is	a	significant	diagnosis	because	of	its	ability	to	affect	almost	every	vital	body	system.• Heart Failure - Heart	failure	is	the	most	common	complication	from	IE	and	can	often	leads	to	surgical	intervention	(Habib,	et.	al,	2015,	p.	26).	Myocardial	tissue	death	from	a	bacterial	vegetation	causes	valvular insufficiency	and	regurgitation,	leading	to	heart	failure.	• Uncontrolled Infection – IE	can	lead	to	a	persisting	infection	(positive	blood	cultures	for	greater	than	7-10	days)	and	a	perivalvular extension	of	the	original	infection.	Some	pathogens	in	IE	can	be	resistant	to	antibiotics	and	be	even	more	difficult	to	treat.	According	to	Habib,	et.	al.,	(2015),	“Perivalvular extension	of	IE	is	the	most	frequent	cause	of	uncontrolled	infection	and	is	associated	with	a	poor	prognosis	and	high	likelihood	of	the	need	for	surgery”	(p.	26).	• Embolism – Embolic	events	are	very	frequent	(up	to	25%	have	already	occurred	upon	diagnosis	of	IE)	and	can	be	fatal.	Splenic	and	brain	emboli	are	the	most	common	site	with	left-sided	IE.	Pulmonary	embolism	and	pacer	lead	embolism	are	the	most	common	type	with	right-sided	IE.	The	risk	of	embolism	falls	from	20-50%	to	6-12%	after	IV	antibiotic	initiation	(Habib	et,	al.,	2015,	p.	28).	Therefore,	early	diagnosis	and	initiation	of	IV	antibiotics	in	IE	is	imperative.	• Neurological	complications – According	to	Habib	et	al.	(2015),	Transient	ischemic	attack,	intracerebral	or	subarachnoidal haemorrhage,	brain	abscess,	meningitis,	infectious	(mycotic)	aneurysm	and	toxic	encephalopathy	are	also	seen,	and	firm	evidence	supports	that	additional	clinically	silent	cerebral	embolisms	occur	in	35–60%	of	IE	patients”	(p.	28).• Splenic	complications – When	a	piece	of	the	vegetation	embolizes and	lodges	in	the	spleen	and	infarct	occurs	and	is	often	asymptomatic.	Although	not	as	common,	splenic	abscesses	also	may	occur	and	require	surgical	treatment.	• Cardiac	Disturbances – Myocarditis	and	pericarditis	may	occur	from	abscess	formation	from	IE.	This	may	lead	to	ventricular	arrhythmias	that	often	prove	fatal.	Pericardial	effusions	and	aneurysms	involving	the	pericardium	may	also	occur.	Conduction	abnormalities	such	as	heart	blocks	and	atrial	fibrillation	may	occur	due	to	the	spread	of	infection	beyond	the	endocardium,	through	the	valves	and	into	conduction	pathways.	Myocardial	ischemia	or	myocardial	infarction	may	also	occur	if	an	embolus	travels	to	the	coronary	arteries.	• Renal	Failure – Acute	renal	dysfunction	(ARD)	occurs	in	about	6-30%	of	IE	patients	and	may	worsen	the	prognosis	of	IE	as	ARD	is	independently	associated	with	increased	hospital	mortality	(Habib	et.	al.,	2015,	p.	30)	This	complication	of	IE		may	change	the	dosage	of	IV	antibiotics	to	allow	for	renal	considerations.	
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• Infective	Endocarditis	is	a	serious	condition	associated	that	if	not	treated,	can	lead	to	death.
• IE	has	an	affect	on	many	other	vital	body	systems.	
• IVDU	puts	the	patient	at	risk	for	developing	IE.	
• Key	pathophysiology	points:
• Damage	to	myocardial	tissue	makes	tissue	prone	to	bacterial	attachment.
• IVDU	allows	an	easy	route	for	bacteria	to	enter	the	bloodstream	and	attach	to	the	valve	(vegetation.)
• Vegetation	growth	damages	the	valves	to	dysfunction	and	can	lead	to	other	organ	damage	(as	earlier	discussed.)
• Nurses	must	monitor	patients	with	IE	closely	for	complications.
• Educating	patients	with	IE	on	IVDU	cessation	is	important	to	prevent	reoccurrence.	
